Senior Director, Alzheimer's Market Access Strategy

BiogenCambridge, MA
27dHybrid

About The Position

About This Role We are seeking a highly seasoned market access leader to shape U.S. market access strategy for Biogen’s Alzheimer’s portfolio, with a primary focus on Leqembi (IV and sub‑cutaneous). This senior‑level role carries enterprise‑wide visibility, serving as a key advisor to Biogen’s executive leadership, a strategic partner to Investor Relations, and a critical interface with Biogen’s alliance partners. As a strategic integrator across Biogen’s Market Access & Reimbursement (MA&R) organization, Alzheimer’s commercial teams, and alliance counterparts, the Senior Director will influence asset‑level strategy, communicate performance to the highest levels of the company – including the CEO, executive leadership, and Board of Directors – and shape business‑critical decisions on access, reimbursement, and patient adoption.

Requirements

  • 15+ years of U.S. Market Access experience with launch leadership in specialty biologics; Alzheimer’s/neuroscience strongly preferred.
  • Bachelor’s degree required; advanced degree (MBA, MPH, MS) preferred.
  • Experience serving as a advisor to senior leadership, including contributions to Investor Relations, earnings preparation, or Board‑level communications.
  • Demonstrated success leading or influencing in alliances/co‑promotions, ideally in situations with high strategic complexity.
  • Deep expertise in Medicare (Part B & D), coding/certification pathways, reimbursement mechanics, site‑of‑care economics, and patient support/HUB models.
  • Proven ability to define KPIs, derive insights, and lead high‑stakes business reviews.
  • Executive presence and exceptional communication skills, including the ability to elevate technical or detailed market access info into crisp narratives for ELT and Board audiences.
  • Track record of leading cross‑functional teams and driving impact across large, complex organizations.

Responsibilities

  • Shape the long‑range market access vision for Leqembi IV and SubQ, shaping payer, provider, and site‑of‑care strategies across Medicare (Part B & D), Commercial, and Medicaid channels.
  • Establish deep, trust‑based relationships with Eisai’s market access executives, serving as Biogen’s senior-most MA&R voice within the alliance.
  • Influence strategic choices – including payer strategy, reimbursement initiatives, KPI definitions, SubQ launch positioning, and cross‑company operational alignment.
  • Partner directly with Biogen senior leadership, including preparation and briefing for ELT decision forums, portfolio updates, and business reviews.
  • Lead development of market access content for Investor Relations, including Q&A preparation, earnings support, external messaging alignment, and scenario analyses.
  • Support Board of Directors preparation, shaping clear and compelling narratives around Alzheimer’s access, payer trends, reimbursement challenges/opportunities, and alliance performance.
  • Manage governance touchpoints, ensuring Biogen’s perspectives, priorities, and insights shape alliance decisions at senior‑leadership tables.
  • Shape the Alzheimer’s access KPI and performance framework, including definition of metrics, dashboard design, insights generation, and monthly/quarterly business reviews with Biogen and Eisai leadership.
  • Translate complex access dynamics into executive‑ready storytelling, ensuring clarity across internal stakeholders.
  • Guide overall cross‑functional strategic alignment, translating policy, evidence, reimbursement, and trade dynamics into clear strategy, launch plans, execution priorities, and risk‑mitigation pathways for both IV and SubQ formulations.
  • Partner closely with alliance and internal stakeholders to ensure Access & Reimbursement Managers (ARMs) and Field Reimbursement teams receive clear direction and real‑time insights that translate strategy into measurable execution improvement
  • Regular Travel Required

Benefits

  • Medical, Dental, Vision, & Life insurances
  • Fitness & Wellness programs including a fitness reimbursement
  • Short- and Long-Term Disability insurance
  • A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
  • Up to 12 company paid holidays + 3 paid days off for Personal Significance
  • 80 hours of sick time per calendar year
  • Paid Maternity and Parental Leave benefit
  • 401(k) program participation with company matched contributions
  • Employee stock purchase plan
  • Tuition reimbursement of up to $10,000 per calendar year
  • Employee Resource Groups participation
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service